WO2008035172A3 - Pharmaceutical compositions containing desmopressin - Google Patents

Pharmaceutical compositions containing desmopressin Download PDF

Info

Publication number
WO2008035172A3
WO2008035172A3 PCT/IB2007/002702 IB2007002702W WO2008035172A3 WO 2008035172 A3 WO2008035172 A3 WO 2008035172A3 IB 2007002702 W IB2007002702 W IB 2007002702W WO 2008035172 A3 WO2008035172 A3 WO 2008035172A3
Authority
WO
WIPO (PCT)
Prior art keywords
pharmaceutical compositions
compositions containing
desmopressin
containing desmopressin
processes
Prior art date
Application number
PCT/IB2007/002702
Other languages
French (fr)
Other versions
WO2008035172A2 (en
Inventor
Madhusudan Dutta
Ulhas Rameshchandra Dhuppad
Kamal Mehta
Original Assignee
Glenmark Pharmaceuticals Ltd
Madhusudan Dutta
Ulhas Rameshchandra Dhuppad
Kamal Mehta
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glenmark Pharmaceuticals Ltd, Madhusudan Dutta, Ulhas Rameshchandra Dhuppad, Kamal Mehta filed Critical Glenmark Pharmaceuticals Ltd
Publication of WO2008035172A2 publication Critical patent/WO2008035172A2/en
Publication of WO2008035172A3 publication Critical patent/WO2008035172A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/095—Oxytocins; Vasopressins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

A pharmaceutical compositions in solid dosage form comprising desmopressin or a pharmaceutically accept salt thereof as the therapeutically active ingredient, and processes for its preparation are disclosed.
PCT/IB2007/002702 2006-09-18 2007-09-18 Pharmaceutical compositions containing desmopressin WO2008035172A2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
IN1483/MUM/2006 2006-09-18
IN1483MU2006 2006-09-18
US85255206P 2006-10-18 2006-10-18
US60/852,552 2006-10-18

Publications (2)

Publication Number Publication Date
WO2008035172A2 WO2008035172A2 (en) 2008-03-27
WO2008035172A3 true WO2008035172A3 (en) 2009-04-23

Family

ID=39200891

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2007/002702 WO2008035172A2 (en) 2006-09-18 2007-09-18 Pharmaceutical compositions containing desmopressin

Country Status (1)

Country Link
WO (1) WO2008035172A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114432424B (en) * 2021-12-27 2023-06-27 南通联亚药业股份有限公司 Stable aluminum-plastic package desmopressin tablet

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20010019719A1 (en) * 1997-04-03 2001-09-06 Point Biomedical Corporation Intravesical drug delivery system
US20020071869A1 (en) * 2000-08-22 2002-06-13 Petr Bures Microparticle composition and method
US20040001887A1 (en) * 1998-08-25 2004-01-01 Levine Howard L. Bioadhesive progressive hydration tablets

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20010019719A1 (en) * 1997-04-03 2001-09-06 Point Biomedical Corporation Intravesical drug delivery system
US20040001887A1 (en) * 1998-08-25 2004-01-01 Levine Howard L. Bioadhesive progressive hydration tablets
US20020071869A1 (en) * 2000-08-22 2002-06-13 Petr Bures Microparticle composition and method

Also Published As

Publication number Publication date
WO2008035172A2 (en) 2008-03-27

Similar Documents

Publication Publication Date Title
WO2011076749A3 (en) Solid pharmaceutical dosage form of ticagrelor
AP2405A (en) Cannabinoid active pharmaceutical ingredient for improved dosage forms.
IL185390A (en) Solid pharmaceutical dosage formulation
WO2008037716A3 (en) Pharmaceutical compositions comprising nilotinib or its salt
WO2007009806A3 (en) Solid dosage formulations of narcotic drugs having improved buccal adsorption
WO2009081174A3 (en) Anti - retroviral combination
IL184758A0 (en) New pharmaceutical compositions useful in the transmucosal administration of drugs
WO2007146248A3 (en) Stable laquinimod preparations
ZA200807767B (en) Nitrogenated heterocyclic derivative, and pharmaceutical agent comprising the derivative as active ingredient
WO2009062746A3 (en) Topical drugs for use in antifungal therapy
WO2007135193A3 (en) Sustained-release alcohol-resistant multimicroparticulate oral pharmaceutical form comprising anti-misuse means
WO2006138735A3 (en) Gel compositions for topical administration
WO2007016284A3 (en) Pharmaceutical formulations/composition of guanfacine suitable for single dose form adminstration daily
WO2010021607A3 (en) Pharmaceutical formulation
ZA200709788B (en) Cannabinold active pharmaceutical ingredient for Improved dosage forms
WO2007144169A3 (en) Entacapone-derivatives
IL201730A (en) Derivatives of 1h-benzoimidazol-2-yl-propyl-methyl-amino-ethyl-5-aryl-bicyclo[2.2.2]oct-5-en-2-ol, pharmaceutical compositions comprising them and their use in the manufacture of medicaments
WO2008129501A3 (en) Pharmaceutical compositions of duloxetine
WO2008003050A3 (en) Gallium nitrate formulations
IL181022A0 (en) Novel benzamidine derivatives, process for the preparation thereof and pharmaceutical compositions comprising the same
WO2007095661A8 (en) Peptides and peptide derivatives, the production thereof as well as their use for preparing a therapeutically and/or preventively active pharmaceutical composition
SI1742927T1 (en) Butanoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic applications threreof
WO2007083190A8 (en) Water insoluble helichrysum extract, process for preparing the same and uses thereof
IL187575A (en) Benzofuranyl derivatives ,pharmaceutical formulations comprising the same and use thereof in the preparation of medicaments for the treatment of 5-ht6-receptor related disorders
WO2007098945A3 (en) Stable solid dosage form comprising desmopressin

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07825134

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 07825134

Country of ref document: EP

Kind code of ref document: A2